Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
I. Gyselinck,L. Liesenborghs,6 Authors,on behalf of Lena consortium
2021 · DOI: 10.1186/s13063-021-05153-4
Trials · 0 Citations
TLDR
An amendment to this paper has been published and can be accessed via the original article.
Abstract
An amendment to this paper has been published and can be accessed via the original article.